Page 49 - AN-3-4

Advanced Neurology Anticoagulants as neuroprotective therapeutics

treatment with dabigatran alters protein expression patterns doi: 10.1016/j.ijcrp.2024.200282
in a late-stage tau-based Alzheimer’s disease mouse model. 133. Ho BL, Hsieh SW, Chou PS, Yang YH. Effects of dabigatran
Biochem Biophys Rep. 2020;24:100862.
on dementia pathogenesis and neuropsychological function:
doi: 10.1016/j.bbrep.2020.100862 A review. J Alzheimers Dis. 2022;86(4):1589-1601.
124. Bunch TJ, May HT, Cutler MJ, et al. Impact of anticoagulation doi: 10.3233/JAD-215513
therapy on the cognitive decline and dementia in patients 134. Zhang C, Gu Z-C, Shen L, et al. Non-vitamin K antagonist
with non-valvular atrial fibrillation (cognitive decline and oral anticoagulants and cognitive impairment in atrial
dementia in patients with non-valvular atrial fibrillation fibrillation: Insights from the meta-analysis of over
(CAF) Trial. J Arrhythm. 2022;38:997-1008. 90,000 patients of randomized controlled trials and real-
doi: 10.1002/joa3.12781 world studies. Front Aging Neurosci. 2018;10:258.
125. Agarwal R, Tully PJ, Mahajan R. Cognitive function in atrial doi: 10.3389/fnagi.2018.00258
fibrillation: A narrative review of evidence and mechanisms. 135. Sagris D, Ntaios G, Buckley BJR, et al. Direct oral
Heart Mind. 2024;8(2):100-110. anticoagulants are associated with lower risk of dementia
doi: 10.4103/hm.HM-D-23-00075 in patients with atrial fibrillation. Eur J Intern Med.
2024;121:114-120.
126. Friberg L, Andersson T, Rosenqvist M. Less dementia and
stroke in low-risk patients with atrial fibrillation taking oral doi: 10.1016/j.ejim.2023.10.033
anticoagulation. Eu Heart J. 2019;40(28):2327-2335. 136. Chen N, Lutsey PL, MacLehose RF, et al. Association of oral
doi: 10.1093/eurheartj/ehz304 anticoagulant type with risk of dementia among patients
with nonvalvular atrial fibrillation. J Am Heart Assoc.
127. Mongkhon P, Fanning L, Lau WCY, et al. Oral anticoagulant 2018;7(6):e009561.
and reduced risk of dementia in patients with atrial
fibrillation: A population-based cohort study. Heart Rhythm. doi: 10.1161/JAHA.118.009561
2020;17(5 Pt A):706-713. 137. Lee SR, Choi EK, Park SH, et al. Comparing warfarin and 4
doi: 10.1016/j.hrthm.2020.01.007 direct oral anticoagulants for the risk of dementia in patients
with atrial fibrillation. Stroke. 2021;52(11):3459-3468.
128. Rahman AA, Michaud J, Dell’Aniello S, et al. Oral
anticoagulants and the risk of dementia in patients with doi: 10.1161/STROKEAHA.120.033338
nonvalvular atrial fibrillation: A population-based cohort 138. Hsu JY, Liu PPS, Liu AB, Lin SM, Huang HK, Loh CH.
study. Neurology. 2023;100(12):e1309-e1320. Lower risk of dementia in patients with atrial fibrillation
doi: 10.1212/WNL.0000000000206748 taking non-vitamin K antagonist oral anticoagulants:
A nationwide population-based cohort study. J Am Heart
129. Jacobs V, May HT, Bair TL, et al. Long-term population- Assoc. 2021;10(5):e016437.
based cerebral ischemic event and cognitive outcomes of
direct oral anticoagulants compared with warfarin among doi: 10.1161/JAHA.120.016437
long-term anticoagulated patients for atrial fibrillation. Am 139. Kim D, Yang PS, Jang E, et al. Association of anticoagulant
J Cardiol. 2016;118(2):210-214. therapy with risk of dementia among patients with atrial
doi: 10.1016/j.amjcard.2016.04.039 fibrillation. Europace. 2021;23(2):184-195.
130. Cheng W, Liu W, Li B, Li D. Relationship of anticoagulant doi: 10.1093/europace/euaa192
therapy with cognitive impairment among patients with 140. Bezabhe WM, Bereznicki LR, Radford J, et al. Oral
atrial fibrillation. A meta-analysis and systemic review. anticoagulant treatment and the risk of dementia in patients
J Cardiovasc Pharmocol. 2018;71(6):380-387. with atrial fibrillation: A population-based cohort study.
doi: 10.1097/FJC.0000000000000575 J Am Heart Assoc. 2022;11(7):e023098.
131. Mongkhon P, Naser AY, Fanning L, et al. Oral anticoagulants doi: 10.1161/JAHA.121.023098
and risk of dementia: A systematic review and meta-analysis 141. Lee ZX, Ang E, Lim XT, Arain SJ. Association of risk of
of observational studies and randomized controlled trials. dementia with direct oral anticoagulants versus warfarin use
Neurosci Biobehav Rev. 2019;96:1-9. in patients with non-valvular atrial fibrillation: A systematic
review and meta-analysis. J Cardiovas Pharmacol.
doi: 10.1016/j.neubiorev.2018.10.025
2021;77(1):22-31.
132. Latif F, Nasir MM, Meer KK, et al. The effect of oral
anticoagulants on the incidence of dementia in patients with doi: 10.1097/FJC.0000000000000925
atrial fibrillation: A systematic review and meta-analysis. Int 142. Wang W, Fan W, Su Y, Hong K. A comparison of the effects
J Cardiol Cardiovasc Risk Prev. 2024;21:200282. of NOAC and VKA therapy on the incidence of dementia

Volume 3 Issue 4 (2024) 31 doi: 10.36922/an.3799